| # | Title | Journal | Year | Citations |
|---|
| 1 | A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) | Blood | 2010 | 805 |
| 2 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 458 |
| 3 | Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities | American Journal of Surgical Pathology | 2004 | 392 |
| 4 | Renal Failure in Multiple Myeloma | Archives of Internal Medicine | 1998 | 328 |
| 5 | Mantle cell lymphoma | | 1998 | 302 |
| 6 | Psychiatric Morbidity and Impact on Hospital Length of Stay Among Hematologic Cancer Patients Receiving Stem-Cell Transplantation | Journal of Clinical Oncology | 2002 | 279 |
| 7 | p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas | Blood | 1998 | 266 |
| 8 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2021 | 265 |
| 9 | Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia | Blood | 2017 | 193 |
| 10 | Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? | Blood | 2014 | 185 |
| 11 | Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species | Blood | 2001 | 184 |
| 12 | A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts | Lancet Oncology, The | 2018 | 165 |
| 13 | Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact | Blood | 2019 | 164 |
| 14 | Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation | Journal of Clinical Oncology | 2005 | 156 |
| 15 | Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis | Blood | 2010 | 153 |
| 16 | Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project | Cytometry Part B - Clinical Cytometry | 2018 | 133 |
| 17 | Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clínic of Barcelona experience | Blood | 2009 | 132 |
| 18 | Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia | Blood | 2006 | 130 |
| 19 | Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both | Leukemia | 2016 | 130 |
| 20 | International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) | Blood Cancer Journal | 2020 | 126 |
| 21 | Veno-occlusive disease of the liver after hemopoietic cell transplantation | European Journal of Haematology | 2000 | 124 |
| 22 | The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab | British Journal of Haematology | 2010 | 122 |
| 23 | The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings | Blood | 2001 | 118 |
| 24 | New prognostic markers in chronic lymphocytic leukemia | Blood Reviews | 2008 | 118 |
| 25 | Chronic lymphocytic leukemia and autoimmunity: a systematic review | Haematologica | 2011 | 117 |
| 26 | Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling | Blood | 2013 | 107 |
| 27 | Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status | Leukemia | 2001 | 105 |
| 28 | Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 105 |
| 29 | Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors | International Journal of Radiation Oncology Biology Physics | 2004 | 100 |
| 30 | Nuclear Survivin Expression in Mantle Cell Lymphoma Is Associated with Cell Proliferation and Survival | American Journal of Pathology | 2004 | 92 |
| 31 | Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2016 | 87 |
| 32 | Genetic Imbalances in Progressed B-Cell Chronic Lymphocytic Leukemia and Transformed Large-Cell Lymphoma (Richter's Syndrome) | American Journal of Pathology | 2002 | 86 |
| 33 | Pathogenesis and progression of monoclonal gammopathy of undetermined significance | Leukemia | 2008 | 86 |
| 34 | INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene | American Journal of Pathology | 2000 | 83 |
| 35 | High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies | Blood | 2018 | 83 |
| 36 | Leukemic involvement is a common feature in mantle cell lymphoma | Cancer | 2007 | 82 |
| 37 | Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma | Haematologica | 2021 | 81 |
| 38 | Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI | American Journal of Hematology | 2017 | 79 |
| 39 | Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center | Bone Marrow Transplantation | 2010 | 77 |
| 40 | Transplantation for multiple myeloma: who, when, how often? | Blood | 2003 | 76 |
| 41 | Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation | Bone Marrow Transplantation | 2005 | 75 |
| 42 | Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma | Haematologica | 2014 | 69 |
| 43 | Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings | Blood | 2002 | 68 |
| 44 | Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations | British Journal of Haematology | 2021 | 67 |
| 45 | Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper | Infection | 2021 | 63 |
| 46 | Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure | Cancer | 2018 | 61 |
| 47 | Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: demonstration of a graft-versus-myelofibrosis effect | Bone Marrow Transplantation | 2000 | 57 |
| 48 | The Expression of the Endoplasmic Reticulum Stress Sensor BiP/GRP78 Predicts Response to Chemotherapy and Determines the Efficacy of Proteasome Inhibitors in Diffuse Large B-Cell Lymphoma | American Journal of Pathology | 2011 | 57 |
| 49 | Extramedullary disease in multiple myeloma: a systematic literature review | Blood Cancer Journal | 2022 | 57 |
| 50 | Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model | Haematologica | 2014 | 56 |
